In Silico QSAR Studies on N-Aryl-Oxazolidinone-5-carboxamides as Novel HIV-1 Protease Inhibitors
Mishra, S., Tripathi, A. (2023). In Silico QSAR Studies on N-Aryl-Oxazolidinone-5-carboxamides as Novel HIV-1 Protease Inhibitors. EKB Journal Management System, 66(13), 2343-2355. doi: 10.21608/ejchem.2023.145331.6333
Saloni Mishra; Arvind Tripathi. "In Silico QSAR Studies on N-Aryl-Oxazolidinone-5-carboxamides as Novel HIV-1 Protease Inhibitors". EKB Journal Management System, 66, 13, 2023, 2343-2355. doi: 10.21608/ejchem.2023.145331.6333
Mishra, S., Tripathi, A. (2023). 'In Silico QSAR Studies on N-Aryl-Oxazolidinone-5-carboxamides as Novel HIV-1 Protease Inhibitors', EKB Journal Management System, 66(13), pp. 2343-2355. doi: 10.21608/ejchem.2023.145331.6333
Mishra, S., Tripathi, A. In Silico QSAR Studies on N-Aryl-Oxazolidinone-5-carboxamides as Novel HIV-1 Protease Inhibitors. EKB Journal Management System, 2023; 66(13): 2343-2355. doi: 10.21608/ejchem.2023.145331.6333